Investor mix
11 investors on record; lead investors include DSC Investment, BM Korea, Korea Investment Value Asset Management, Prodigy Investment.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 36% |
| Private equity | 1 | 9% |
| Other / undisclosed | 6 | 55% |
Developer of anticancer drugs using cancer metabolism
11 investors on record; lead investors include DSC Investment, BM Korea, Korea Investment Value Asset Management, Prodigy Investment.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 36% |
| Private equity | 1 | 9% |
| Other / undisclosed | 6 | 55% |